<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The following reference bacterial and fungal strains were used in the studies: 
 <italic class="italic">Staphylococcus aureus</italic> ATCC 25923, 
 <italic class="italic">Staphylococcus epidermidis</italic> ATCC 12228, 
 <italic class="italic">Escherichia coli</italic> ATCC 25922, 
 <italic class="italic">Pseudomonas aeruginosa</italic> ATCC 27853, 
 <italic class="italic">Mycobacterium smegmatis</italic> ATCC 607, 
 <italic class="italic">Mycobacterium smegmatis</italic> ATCC 19420, 
 <italic class="italic">Mycobacterium tuberculosis</italic> H37Ra ATCC 25177, 
 <italic class="italic">Candida albicans</italic> ATCC 10231, and 
 <italic class="italic">Candida parapsilosis</italic> ATCC 22019. All microbial strains stocks except mycobacteria were stored in −70 °C in Viabank vials (Medical Wire &amp; Equipment Co. Ltd., Corsham, UK). Mycobacteria were stored in −70 °C in Middlebrook 7H9 broth (Difco Laboratories Inc., Detroit, MI, USA) with 10% albumin dextrose complex (ADC; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) supplemented with 15% glycerol. All microbiological procedures were made according to Clinical and Laboratory Standards Institute [
 <xref rid="B39-molecules-23-00256" ref-type="bibr" class="xref">39</xref>,
 <xref rid="B40-molecules-23-00256" ref-type="bibr" class="xref">40</xref>].
</p>
